Connect
MJA
MJA

Toxicity from bodybuilding supplements and recreational use of products containing 1,3-dimethylamylamine

Jared A Brown and Nick A Buckley
Med J Aust 2013; 198 (8): 414-415. || doi: 10.5694/mja12.11167
Published online: 20 May 2013

To the Editor: 1,3-Dimethylamylamine (DMAA) is a substance with amphetamine-like effects found in bodybuilding and weight-loss products and recreational drugs (also marketed as methylhexaneamine, dimethylpentylamine and geranium).1 DMAA was recently banned in Australia and other countries owing to toxicity, lack of health benefits, and concerns about long-term safety and potential for misuse.2 However, published evidence for safety concerns has been remarkably limited; just a few cases report cerebral haemorrhage and cardiomyopathy.1

  • Jared A Brown1
  • Nick A Buckley1,2

  • 1 NSW Poisons Information Centre, Children’s Hospital Network (Westmead), Sydney, NSW.
  • 2 University of New South Wales, Sydney, NSW.

Correspondence: jared.brown@sydney.edu.au

Acknowledgements: 

We thank Angela Chiew for assisting with data collection.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.